Expression of the multidrug resistance-associated protein (MRP) and chemoresistance of human non-small-cell lung cancer cells

International Journal of Cancer

Volumn 73, Issue 1, 1997, Pages 84-93

  Berger, Walter ^a   Elbling, Leonilla ^a   Hauptmann, Erich ^a   Micksche, Michael ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; FEMALE; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MALE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; TREATMENT FAILURE;

AGED; ATP-BINDING CASSETTE TRANSPORTERS; CARCINOMA, NON-SMALL-CELL LUNG; DAUNORUBICIN; DRUG RESISTANCE, MULTIPLE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0030802692     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970926)73:1<84::AID-IJC14>3.0.CO;2-5     Document Type: Article

References (33)

1. BAI, F., NAKANISHI, Y., KAWASAKI, M., TAKAYAMA, K., YATSUNAMI, J., PEI, X.H., TSURUTA, N., WAKAMATSU, K. and HARA, N., Immunohistochemical expression of glutathione S-transferase-Pi can predict chemotherapy response in patients with non-small cell lung carcinoma. Cancer, 78, 416-421 (1996).
2. BELLAMY, W.T. and DALTON, W.S. Multidrug resistance in the laboratory and clinic. Adv. clin. Chem., 31, 1-61 (1994).
3. BERGER, W., ELBLING, L., MINAI-POUR, M., VETTERLEIN, M., PIRKER, R., KOKOSCHKA, E.M. and MICKSCHE, M., Intrinsic MDR-1 and P-glycoprotein expression in human malignant melanoma. Int. J. Cancer, 59, 717-723 (1994).
4. BERGER, W., E. HAUPMANN, ELBLING, L., VETTERLEIN, M., KOKOSCHKA, E.M. and MICKSCHE, M., Possible role of the multidrug resistance-associated protein (MRP) in chemoresistance of human melanoma cells. Int. J. Cancer, 71, 108-115 (1997).
5. BERGH, J., NYGRÉN, P. and LARSSON, R., Mechanisms for acquired cytotoxic drug resistance in human small cell lung cancer and the potential utilization of resistance modifiers - a review with focus on in vitro studies. Lung Cancer 6, 9-15 (1990).
6. BORING, C.C., SQUIRES, T.S. and TONG, T., Cancer statistics, 1993. CA Cancer J. Clin., 43, 7-26 (1993).
7. BROXTERMAN, H.J., GIACCONE, G. and LANKELMA, J., Multidrug resistance proteins and other drug transport-related resistance to natural product agents. Curr. Opin. Oncol., 7, 532-540 (1995).
8. CARMICHAEL, J., MITCHELL, J.B., FRIEDMAN, N., GAZDAR, A.F. and RUSSO, A., Glutathione and related enzyme activity in human lung cancer cell lines. Brit. J. Cancer, 58, 437-440 (1988).
9. CHUMAN, Y. SUMIZAWA, T., TAKEBAYASHI, Y. NIWA, K., YAMADA, K., HARAGUCHI, M., FURUKAWA, T., AKIYAMA, S. and AIKOU, T., Expression of the multidrug-resistance-associated protein (MRP) gene in human colorectal, gastric and non-small-cell lung carcinomas. Int. J. Cancer, 66, 274-279 (1996).
10. COLE, S.P.C., BHARDWAJ, G., GERLACH, J.H., MACKIE, J.E., GRANT, C.E., ALMQUIST, K.C., STEWARD, A.J., KURZ, E.U., DUNCAN, A.M.V. and DEELEY., R.G., Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science, 258, 1650-1654 (1992).
11. COLE, S.P.C., SPARKS, K.E., FRASER, K., LOE, D.W., GRANT, C.E., WILSON, G.M. and DEELEY, R.G., Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res., 54, 5902-5910 (1994).
12. DOYLE, L.A., Mechanisms of drug resistance in human lung cancer cells. Semin. Oncol., 20, 326-337 (1993).
13. EIJDEMS, E.W.H.M., DE HAAS, M., COCO-MARTIN, J.M., OTTENHEIM, C.P.E., ZAMAN, G.J.R., DAUWERSE, H.G., BREUNING, M.H., TWENTYMAN, P.R., BORST, P. and BAAS, F., Mechanisms of MRP over-expression in four human lung-cancer cell lines and analysis of the MRP amplicon. Int. J. Cancer, 60, 676-684 (1995).
14. GEKELER, V., ISE, W., SANDERS, K.H., ULRICH, W.R. and BECK, J., The leukotriene LTD4 receptor antagonist MK571 specifically modulates MRP associated multidrug resistance. Biochem. biophys. Res. Comm., 208, 345-352 (1995).
15. GIACCONE, G., GAZDAR, A.F., BECK, H., ZUNINO, F. and CAPRANICO, G., Multidrug sensitivity phenotype of human lung cancer cells associated with topoisomerase II expression. Cancer Res., 52, 1666-1674 (1992).
16. GIACCONE, G., VAN ARK-OTTE, J., RUBIO, G.J., GAZDAR, A.F., BROXTERMAN, H.J., DINCEMANS, A.M.C., FLENS, M.J., SCHEPER, R.J. and PINEDO, H.M., MRP is frequently expressed in human lung-cancer cell lines, in non-small-cell lung cancer and in normal lung. Int. J. Cancer, 66, 760-767 (1996).
17. GOTTESMAN, M.M. and PASTAN, I., Biochemistry of multidrug resistance mediated by the multidrug transporter. Ann. Rev. Biochem., 62, 385-427 (1993).
18. HOLLO, Z., HOMOLYA, L., HEGEDÜS, T. and SARKADI, B., Transport properties of the multidrug resistance-associated protein (MRP) in human tumour cells. FEBS Lett., 383, 99-104 (1996).
19. HlNDENBURG, A.A., GERVASONI, J.E., KRISHNA, S., STEWARD, V.J., ROSADO, M., LUTZKY, J., BHALLA, K., BAKER, M.A. and TAUB, R.N., Intracellular distribution and pharmacokinetics of daunorubicin in anthrucycline-sensitive and resistant HL-60 cells. Cancer Res., 49, 4607-4614 (1989).
20. IHDE, D.C., Chemotherapy of lung cancer. N. Engl. J. Med., 327, 1434-1441 (1992).
21. IZQVIERDO, M.A., SHOEMAKER, R.H., FLENS, M.J., SCHEFFER, G.L., Wu, L., PRATHER, T.R. and SCHEPER, R.J., Overlapping phenotypes of multidrug resistance among panels of human cancer-cell lines. Int. J. Cancer, 65, 230-237 (1996).
22. JEDLITSCHKY, G., LEIER, I., BLCHHOLZ, U., CENTER, M. and KEPPLER, D., ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein. Cancer Res., 54, 4833-4836 (1994).
23. LEGRAND, O., PERROT, J.Y., TANG, R.P., SIMONIN, G., GURBUXANI, S., ZITTOUN, R. and MARIE, J.P., Expression of the multidrug-resistunce-associated protein (MRP) mRNA and protein in normal peripheral blood and bone marrow haemopoietic cells. Brit. J. Haematol, 94, 23-33 (1996).
24. LIU, R.J., Chemotherapy outcome in advanced non-small-cell lung carcinoma. Semin. Oncol., 20, 296-301 (1993).
25. LOE, D.W., DEELEY, R.G. and COLE, S.P.C., Biology of the multidrug resistance-associated protein, MRP, Europ. J. Cancer, 32A, 945-957 (1996).
26. NARASAKI, F., MATSUO, I., IKUNO, N., FUKUDA, M., SODA, H. and OKA, M., Multidrug resistance-associated protein (MRP) gene expression in human lung cancer. Anticancer Res., 16, 2079-2082 (1996).
27. NOOTER, K., BOSMAN, F.T., BURGER, H., VAN WINGERDEN, K.E., FLENS, M.J., SCHEPER, R.J., OOSTRUM, R.G., BOERSMA, A.W.M., VAN DER GAAST, A. and STOTER, G., Expression of the multidrug resistance-associated protein (MRP) gene in primary non-small-cell lung cancer. Ann. Oncol., 7, 75-81 (1996).
28. OTA, E., ABE, Y., OSHIKA, Y., OZEKI, Y., IWASAKI, M., INOUE, H., YAMAZAKI, H., UEYAMA, Y., TAKAGI, K., OGATA, T., TAMAOKI, N. and NAKAMURA, M., Expression of the multidrug resistance-associated protein (MRP) gene in non-small-cell lung cancer. Brit. J. Cancer, 72, 550-554 (1995).
29. SUGAWARA, I., YAMADA, H., NAKAMURA, H., SUMIZAWA, T., AKTYAMA, S., MASUNAGA, A. and ITOYAMA, S., Preferential expression of the multidrug-resistance-associated protein (MRP) in adenocarcinoma of the lung. Int. J. Cancer. 64, 322-325 (1995).
30. THOMAS, G.A., BARRAND, M.A., STEWARD, S., RABBITTS, P.M., WILLIAMS, E.D. and TWENTYMAN, P.R., Expression of the multidrug resistance-associated protein (MRP) gene in human lung tumours and normal tissue as determined by in situ hybridisation. Europ. J. Cancer, 30A, 1705-1709 (1994).
31. TWENTYMAN, P.R. and VERSANTVOORT, C.H.M., Experimental modulation of MRP (multidrug resistance-associated protein)-mediated resistance. Europ. J. Cancer, 32A, 1002-1009 (1996).
32. ZAMAN, G.J.R., VERSANTVOORT, C.H.M., SMIT, J.J.M., EIJDEMS, E.W.H.M., DE HAAS, M., SMITH, A.J., BROXTERMAN, H.J., MULDER, N.H., DE VRIES, E.G.E., BAAS, F. and BORST, P., Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines. Cancer Res., 53, 1747-1750 (1993).
33. ZIJLSTRA, J.G., DE VRIES, E.G.E, and MULDER, N.H., Multifactorial drug resistance in an Adriamycin-resistant human small cell lung carcinoma cell line. Cancer Res., 47, 1780-1784 (1987).